Viewing Study NCT00276861


Ignite Creation Date: 2025-12-24 @ 11:48 AM
Ignite Modification Date: 2025-12-30 @ 4:32 PM
Study NCT ID: NCT00276861
Status: TERMINATED
Last Update Posted: 2017-02-08
First Post: 2006-01-12
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Metastatic Colon Cancer
Sponsor: University of Miami
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adenocarcinoma of the colon View
None recurrent colon cancer View
None stage IV colon cancer View